A RETROSPECTIVE ANALYSIS OF SECOND-LINE CHEMOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA (MPM)

被引：0
|
作者：
Bramati, A. [1 ]
Moretti, A. [1 ]
Garassino, M. C. [2 ]
Califano, R. [3 ]
Farina, G. [4 ]
Lo Dico, M. [5 ]
Cinquini, M. [6 ]
Michetti, G. N. [7 ]
Tiseo, M. [8 ]
Zucali, P. A. [9 ]
机构：
[1] AO Osped Fatebenefratelli Oftalmico, Milan, Italy
[2] Fatebenefratelli & Ophtalm Hosp, Milan, Italy
[3] Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England
[4] Osped Fatebenefratelli Oftalmico, Milan, Italy
[5] Civil Hosp Livorno, Div Med Oncol, Livorno, Italy
[6] Mario Negri Inst Pharmacol Res, Milan, Italy
[7] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
[8] Parma Hosp, Parma, Italy
[9] IRCCS, Ist Clin Humanitas, Dept Oncol, Rozzano, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S103 / S103
页数：1
相关论文
共 50 条
  • [1] A retrospective analysis of second-line chemotherapy for malignant pleural mesothelioma (MPM)
    La Verde, N. M.
    Bramati, A.
    Cinquini, M.
    Tiseo, M.
    Collova, E.
    Michetti, A.
    Lo Dico, M.
    Foliador, A.
    Garassino, M. C.
    Zucaii, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Second-line chemotherapy in malignant pleural mesothelioma: Results of a retrospective multicenter survey
    Zucali, P. A.
    Simonelli, M.
    Michetti, G.
    Tiseo, M.
    Ceresoli, G. L.
    Collova, E.
    Follador, A.
    Lo Dico, M.
    Moretti, A.
    De Vincenzo, F.
    Lorenzi, E.
    Perrino, M.
    Giordano, L.
    Farina, G.
    Santoro, A.
    Garassino, M.
    LUNG CANCER, 2012, 75 (03) : 360 - 367
  • [3] NGR-hTNF as second-line treatment in malignant pleural mesothelioma (MPM)
    Rossoni, Gilda
    Gregorc, Vanesa
    Vigano, Maria Grazia
    Bulotta, Alessandra
    Ghio, Domenico
    Lambiase, Antonio
    Bordignon, Claudio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Second-Line Chemotherapy for Malignant Pleural Mesothelioma (MPM): Patterns of Care in Two Australian Tertiary Institutions
    Palmieri, David
    Hui, Rina
    Kao, Steven
    Boyer, Michael
    Park, John
    Nagrial, Adnan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 134 - 134
  • [5] Phase II study of sunitinib as second-line therapy in malignant pleural mesothelioma (MPM)
    Nowak, A. K.
    Millward, M. J.
    Francis, R.
    van der Schaaf, A.
    Musk, A. W.
    Byrne, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] GemOx as second-line treatment in a selected population of patients with malignant pleural mesothelioma (MPM)
    Mucciarini, C.
    Masoni, F.
    Giovanardi, F.
    Artioli, F.
    ANNALS OF ONCOLOGY, 2006, 17 : XI85 - XI86
  • [7] OUTCOMES OF MALIGNANT PLEURAL MESOTHELIOMA PATIENTS TREATED WITH SECOND-LINE CHEMOTHERAPY (SL): A RETROSPECTIVE ANALYSIS OF 161 PATIENTS
    Garassino, Marina Chiara
    Moretti, Anna
    Cinquini, Michela
    Tiseo, Marcello
    Michetti, Giovanni
    Collova, Elena
    Follador, Alessandro
    Sburlati, Paola
    Farina, Gabriella
    Zucali, Paolo
    ANNALS OF ONCOLOGY, 2009, 20
  • [8] Outcomes of malignant pleural mesothelioma patients treated with second-line chemotherapy (SL): a retrospective analysis of 161 patients
    Garassino, M.
    Moretti, A.
    Cinquini, M.
    Tiseo, M.
    Michetti, G.
    Collova, E.
    Follador, A.
    La Verde, N.
    Farina, G.
    Zucali, P.
    EJC SUPPLEMENTS, 2009, 7 (02): : 543 - 544
  • [9] Second-line treatment for malignant pleural mesothelioma
    Ceresoli, Giovanni Luca
    Zucali, Paolo Andrea
    Gianoncelli, Letizia
    Lorenzi, Elena
    Santoro, Armando
    CANCER TREATMENT REVIEWS, 2010, 36 (01) : 24 - 32
  • [10] Treatment with gemcitabine and vinorelbine (GEMVIN) as second-line chemotherapy in pemetrexed-pretreated patients with malignant pleural mesothelioma (MPM)
    Garassino, Isabella
    Ceresoli, Giovanni L.
    De Vincenzo, Fabio
    Zucali, Paolo A.
    Cavina, Raffaele
    Campagnoli, Elisabetta
    Salamina, Silvia
    Parra, Hector J. Soto
    Santoro, Armando
    ANNALS OF ONCOLOGY, 2006, 17 : 231 - 231
12345